A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)
Clinical trial NCT04198415 · COMPLETED
Trial details
- NCT number
- NCT04198415
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-02-03
- Primary completion
- 2022-10-21
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.